June 23, 24, and 25
The future of brain health takes center stage at I-C3N 2026: the convergence of neurotechnology (MEG/EEG, tACS) and Artificial Intelligence is already making it possible to anticipate Alzheimer’s disease and modulate pathological networks. Together with experts from five nations, we are transforming research into predictive and therapeutic solutions at this new congress organized by C3N (UCM).
Three major trends will be addressed at this ambitious congress:
- Early detection and Machine Learning: We are moving beyond mere observation of the brain; we now use predictive algorithms to anticipate Alzheimer’s and other forms of dementia starting at the preclinical stage, utilizing biomarkers such as the excitation/inhibition balance.
- Active intervention: Technologies like transcranial alternating current stimulation (tACS) are proving capable of desynchronizing pathological networks and generating objective improvements in the memory of at-risk patients.
- Functional connectivity: Brain rhythms are emerging as the fundamental language for deciphering not only successful aging but also critical life transitions, such as adolescent neurodevelopment and motherhood.
Research is moving out of the “data jungle” to create real-world predictive and therapeutic solutions. It is exciting to see how technology continues to unravel the mysteries of the mind!
Comments are closed